(Reuters) – Johnson & Johnson is planning to ask U.S. federal regulators this week to authorize a booster shot of its COVID-19 vaccine, the New York Times reported on Monday, citing officials familiar with the company’s plans.
(Reporting by Aakriti Bhalla in Bengaluru; Editing by Ramakrishnan M.)
